<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tblu16" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Groups</th><th valign="top">Antibody</th><th valign="top">F test statistic</th><th valign="top">Partial &#951;<sup>2</sup></th><th valign="top">Effect size <italic>f</italic></th><th valign="top">A priori power</th><th valign="top">Total sample size</th></tr></thead><tbody><tr><td colspan="7" valign="top">2% variance</td></tr><tr><td rowspan="2" valign="top">MAP3K8 inhibitor (1, 5, 10, 20 &#181;M)</td><td valign="top">pMEK</td><td valign="top">F(3,8) = 1583.7</td><td valign="top">0.99832</td><td valign="top">24.3697</td><td valign="top">99.9%</td><td valign="top">8 <break/>(4 groups)</td></tr><tr><td valign="top">pERK</td><td valign="top">F(3,8) = 195.33</td><td valign="top">0.98653</td><td valign="top">8.55863</td><td valign="top">99.9%</td><td valign="top">8 <break/>(4 groups)</td></tr><tr><td colspan="7" valign="top">15% variance</td></tr><tr><td rowspan="2" valign="top">MAP3K8 inhibitor (1, 5, 10, 20 &#181;M)</td><td valign="top">pMEK</td><td valign="top">F(3,8) = 28.155</td><td valign="top">0.91348</td><td valign="top">3.24931</td><td valign="top">96.8%</td><td valign="top">8 <break/>(4 groups)</td></tr><tr><td valign="top">pERK</td><td valign="top">F(3,8) = 3.4726</td><td valign="top">0.56563</td><td valign="top">1.14114</td><td valign="top">83.6%</td><td valign="top">16 <break/>(4 groups)</td></tr><tr><td colspan="7" valign="top">28% variance</td></tr><tr><td rowspan="2" valign="top">MAP3K8 inhibitor (1, 5, 10, 20 &#181;M)</td><td valign="top">pMEK</td><td valign="top">F(3,8) = 8.0801</td><td valign="top">0.75186</td><td valign="top">1.74070</td><td valign="top">94.7%</td><td valign="top">12 <break/>(4 groups)</td></tr><tr><td valign="top">pERK</td><td valign="top">F(3,8) = 0.9966</td><td valign="top">0.27205</td><td valign="top">0.61133</td><td valign="top">80.8%</td><td valign="top">40 <break/>(4 groups)</td></tr><tr><td colspan="7" valign="top">40% variance</td></tr><tr><td rowspan="2" valign="top">MAP3K8 inhibitor (1, 5, 10, 20 &#181;M)</td><td valign="top">pMEK</td><td valign="top">F(3,8) = 3.9593</td><td valign="top">0.59754</td><td valign="top">1.21849</td><td valign="top">88.7%</td><td valign="top">16 <break/>(4 groups)</td></tr><tr><td valign="top">pERK</td><td valign="top">F(3,8) = 0.4883</td><td valign="top">0.15478</td><td valign="top">0.42793</td><td valign="top">80.5%</td><td valign="top">76 <break/>(4 groups)</td></tr></tbody></table></table-wrap>